blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1834671

EP1834671 - A method for generation of antibodies to cell surface molecules [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.04.2014
Database last updated on 19.07.2024
Most recent event   Tooltip25.04.2014Application deemed to be withdrawnpublished on 28.05.2014  [2014/22]
Applicant(s)For all designated states
Novartis Vaccines and Diagnostics, Inc.
4560 Horton Street
Emeryville, CA 94608 / US
[2007/38]
Inventor(s)01 / De Boer, Mark
Naarderweg 20
1261 BT Blaricum / NL
02 / Conroy, Leah B.
515 Beaumont Boulevard
Pacifica, CA 94044 / US
 [2007/38]
Representative(s)Marshall, Cameron John, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2007/38]Marshall, Cameron John, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date06076491.708.07.1993
[2007/38]
Priority number, dateUS1992091022209.07.1992         Original published format: US 910222
US1993001514709.02.1993         Original published format: US 15147
US1993007015828.05.1993         Original published format: US 70158
[2007/38]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1834671
Date:19.09.2007
Language:EN
[2007/38]
Type: A3 Search report 
No.:EP1834671
Date:22.05.2013
Language:EN
[2013/21]
Search report(s)(Supplementary) European search report - dispatched on:EP23.04.2013
ClassificationIPC:A61P37/00, A61K39/395, C07K16/28, C12N5/12
[2007/38]
CPC:
C07K16/2827 (EP); A61P37/00 (EP); C07K16/2878 (EP);
A61K2039/505 (EP); C07K2317/24 (EP); C07K2317/73 (EP);
C07K2319/30 (EP) (-)
Designated contracting states[2014/05]
Former [2007/38]AT,  BE,  CH,  DE,  DK,  ES,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:Ein Verfahren zur Erregung von Antikörpern gegen Zelloberflächemoleküle[2007/38]
English:A method for generation of antibodies to cell surface molecules[2007/38]
French:Procédé pour l'induction des anticorps contre des molecules exprimées sur la surface des cellules[2007/38]
Examination procedure23.11.2013Application deemed to be withdrawn, date of legal effect  [2014/22]
14.01.2014Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2014/22]
Parent application(s)   TooltipEP93917032.0  / EP0651797
EP99104709.3  / EP0945465
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19930917032) is  13.07.1998
Fees paidRenewal fee
31.07.2006Renewal fee patent year 03
31.07.2006Renewal fee patent year 04
31.07.2006Renewal fee patent year 05
31.07.2006Renewal fee patent year 06
31.07.2006Renewal fee patent year 07
31.07.2006Renewal fee patent year 08
31.07.2006Renewal fee patent year 09
31.07.2006Renewal fee patent year 10
31.07.2006Renewal fee patent year 11
31.07.2006Renewal fee patent year 12
31.07.2006Renewal fee patent year 13
31.07.2006Renewal fee patent year 14
04.07.2007Renewal fee patent year 15
31.03.2008Renewal fee patent year 16
10.07.2009Renewal fee patent year 17
14.07.2010Renewal fee patent year 18
12.07.2011Renewal fee patent year 19
13.07.2012Renewal fee patent year 20
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9200092  (BRISTOL MYERS SQUIBB CO [US]) [A] 1-4,6,7 * page 30, line 16 * * example - ** claim - *;
 [XYI]  - S. LEDERMAN ET AL., "Anti-CD40 monoclonal antibody vblocks the contact dependent T helper signal mediated by 5C8 Ag.", CLINICAL RESEARCH, Thorofare, NJ, USA, (19920101), vol. 40, no. 2, page 154A, XP002176377 [X] 4,6 * abstract * [Y] 1-3 [I] 7
 [Y]  - T. CHANG ET AL., "Monoclonal antibodies specific for human IgE-producing B cells: A potential therapeutic for IgE-mediated allergic diseases.", BIO/TECHNOLOGY, (199002), vol. 8, pages 122 - 126, XP009084134 [Y] 1-3 * abstract * * figure 5 *

DOI:   http://dx.doi.org/10.1038/nbt0290-122
 [IA]  - E. CLARK ET AL., "Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors.", THE JOURNAL OF IMMUNOLOGY, Baltimore, MD, USA, (19900901), vol. 145, no. 5, pages 1400 - 1406, XP002689362 [I] 6 * page 1401, column r, paragraph 2 * * figure 2 * [A] 1-4,7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.